Top Stories
neuralink fda 052623 lg

Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval...

consumer confidence2 053023 lg

Consumer confidence in the U.S. saw a modest decrease from an upwardly revised level in the month of May, according to a report released by the Conference Board on Tuesday. The Conference Board said its consumer confidence index edged down to 102.3...

gobierno pedro 052923 lg

Spain will elect a new parliament in July as Prime Minister Pedro Sanchez has announced snap polls. The surprise move follows major setbacks for the ruling Socialist party in regional and local elections. In an address to the nation, Sanchez said...

wallstreet higher 050119 30may23 lg

After an initial move to the upside, stocks have given back ground over the course of the trading session on Monday. The major averages have pulled back well off their highs of the session and are currently turning in a mixed performance.

bidenkevinmccarthyjanetyelen may23 President Joe Biden and House Speaker Kevin McCarthy have discussed the impasse over the debt ceiling, and described the talks as productive. "I just concluded a productive meeting with Speaker McCarthy about the need to prevent default and avoid a catastrophe for our economy. We reiterated once again that default is off the table and the only way to move forward is in good faith toward a biparti
coloradoriver may23 The Department of the Interior and seven Colorado River Basin states have reached an agreement on a consensus-based approach that marks an important step to protect the stability of the Colorado River System in the face of climate change and historic drought conditions. As part of the Department's continued efforts to address ongoing severe drought conditions and a changing climate in the Colora
jpmorganchase 052423 JPMorgan Chase(JPM) on Tuesday announced its commitment to invest over $200 million in a mix of carbon removal technologies. In a statement, the company announced that the allocated funds will be used for long-term agreements focused on removing and...
wallstreet july20 23may23 U.S. stocks ended notably lower on Tuesday after staying weak right through the day's session due to sustained selling at several counters.
Read More
capitol building 110618 28may23 President Joe Biden and House Speaker Kevin McCarthy, R-Calif., have reached an agreement in principle to raise the debt ceiling and avoid a potentially disastrous default by the U.S. government. Biden called the deal an "an important step forward that reduces spending while protecting critical programs for working people and growing the economy for everyone."
Read More
preview oct30 30may23Economic confidence and monetary aggregates from the euro area are due on Tuesday, headlining a busy day for the European economic news. At 2.00 am ET, final quarterly national accounts and foreign trade figures are due from Sweden. The initial estimates showed that the economy logged a sequential growth of 0.2 percent in the first quarter, reversing a 0.5 percent fall in the fourth quarter.
Read More
paxlovid may26
The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
Read More
Cryptocurrencies remained close to the flatline as the debt limit deadlock progresses to the stage of Congressional approval. Read More
As we step into the third month of the second quarter, let's take a quick look at the regulatory news that made headlines in May and offer you a sneak peek into the anticipated FDA decisions coming up in June. Read More
Drug major Pfizer Inc. (PFE) announced Tuesday that the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab has met its primary endpoints, having demonstrated statically significant and clinically meaningful effects. Marstacimab... Read More
Follow RTT
Economic Calendar
05/30/23 10:0Consumer Confidence IndexMAY United States
05/30/23 9:0House Price Index (M-o-M)MAR United States
05/30/23 9:0S&P/Case-Shiller Home Price IndexMAR United States
05/30/23 9:0S&P/Case-Shiller Composite-20 (Y-o-Y)MAR United States
05/30/23 9:0House Price Index (Q-o-Q)Q1 United States
05/30/23 8:30Current Account Balance - BoPQ1 Canada
View All